Levobunolol Hydrochloride

盐酸左布诺洛尔

Report date: 2022/01/14 13:23:58
NME

Base Information

Drug NameLevobunolol Hydrochloride
Drug Alias Name盐酸左旋布诺洛尔Levobunololum左旋丁酮心安坐布诺洛尔丁酮心安 +[15] 
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionBeta adrenergic receptors antagonists
TargetsBeta adrenergic receptors
Therapy Area/IndicationsGlaucoma, Open-AngleGlaucomaOcular Hypertension
Global Approved IndicationsGlaucoma, Open-AngleGlaucomaOcular Hypertension
Approved Indications in ChinaGlaucomaOcular Hypertension
Original Approved Country/TerritoryUnited States
Original Approved Date1985/12/19
Country/TerritoryUnited StatesMainland China
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesAllergan Plc
China Registration ClassN/A

Develop Information

Active CompaniesAllergan PlcHubei Sihuan Pharmaceutical Co LtdWuhan Binhu Shuanghe Pharmaceutical Co Ltd
Inactive CompaniesN/A
Active IndicationsGlaucoma, Open-AngleGlaucomaOcular Hypertension
Inactive IndicationsN/A

Other Information

ATC CodeS01ED03
Related LinksWikipediaDrugBankKEGG